Interleukin-5 Messenger RNA and Immunoreactive Protein Expression by Activated Eosinophils in Lesional Atopic Dermatitis Skin

This publication has 20 references indexed in Scilit:

• Eosinophil Migration in Atopic Dermatitis I: Increased Migratory Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine, Neutrophil-Activating Factor, Platelet-Activating Factor, and Platelet Factor 4
  Journal of Investigative Dermatology, 1993
• The role of eosinophils in the pathogenesis of atopic dermatitis ‐ eosinophil granule proteins as markers of disease activity
  Allergy, 1993
• Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
  Journal of Clinical Investigation, 1992
• Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.
  The Journal of Experimental Medicine, 1992
• IgE-bearing Langerhans cells are not specific to atopic eczema but are found in inflammatory skin diseases
  Journal of the American Academy of Dermatology, 1991
• Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients.
  The Journal of Experimental Medicine, 1990
• Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.
  The Journal of Experimental Medicine, 1989
• Eosinophils in atopic dermatitis
  Allergy, 1989
• Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
  The Journal of Experimental Medicine, 1988
• Recombinant human interleukin 5 is a selective activator of human eosinophil function.
  The Journal of Experimental Medicine, 1988